ColombiaProduct Registration for Pharmaceuticals in Colombia
Taevas Global guides pharmaceuticals manufacturers through every stage of INVIMA product registration in Colombia, turning complex regulatory requirements into a clear, actionable market entry path. From dossier preparation to approval, we help you enter
Six Pillars of Colombia Pharmaceuticals Intelligence
Our six interconnected pillars provide pharmaceuticals companies with the regulatory clarity, market insight, and strategic support needed to achieve successful product registration in Colombia.
Regulatory Pathway Analysis
We map the precise INVIMA registration pathway applicable to your pharmaceutical product, whether it is a new chemical entity, generic, biologic, or over-the-counter medicine. Our analysis covers Decree 677 of 1995 and subsequent resolutions governing pharmaceutical registration in Colombia. You receive a clear roadmap before a single document is prepared.
From Brief to Board-Ready Intelligence
Our structured four-stage engagement takes pharmaceuticals companies from initial regulatory scoping through a fully submitted and tracked INVIMA dossier, with clear milestones and deliverables at every step.
Regulatory Scoping and Intake
We conduct a detailed intake session to understand your product profile, existing regulatory history, manufacturing site details, and target timelines for Colombia market entry. Our team performs an initial classification assessment under INVIMA's framework and identifies the applicable registration pathway. You receive a written scoping memo outlining the regulatory route, estimated timeline, and key risks.
This stage includes a structured questionnaire covering active pharmaceutical ingredients, dosage form, therapeutic indication, manufacturing site locations, and any prior approvals in reference markets such as the United States, European Union, or Brazil. The output is a concise regulatory strategy memo that serves as the foundation for all subsequent dossier work and client decision-making.
Colombia Pharmaceuticals Market at a Glance
Latin America's Third-Largest Pharma Market
Colombia ranks as the third-largest pharmaceutical market in Latin America by value, behind Brazil and Mexico. The country's expanding middle class, aging population, and increasing health insurance coverage under the Sistema General de Seguridad Social en Salud are driving sustained demand for both branded and generic medicines. This positions Colombia as a strategic priority market for international pharmaceuticals manufacturers.
INVIMA as the Central Regulatory Authority
The Instituto Nacional de Vigilancia de Medicamentos y Alimentos, known as INVIMA, is Colombia's national health regulatory authority responsible for all pharmaceutical product registrations, manufacturing site inspections, and post-market surveillance. INVIMA operates under the Ministry of Health and Social Protection and has been progressively modernizing its evaluation processes, including the introduction of electronic dossier submissions. Understanding INVIMA's evolving procedural requirements is essential for efficient market entry.
Growing Generics and Biosimilars Segment
Colombia's government has actively promoted the use of generic and biosimilar medicines to improve healthcare access and control public expenditure, supported by policies including mandatory generic prescribing in the public health system. The biosimilars segment is growing rapidly following the issuance of Resolution 3610 of 2013 and subsequent regulatory updates governing biological products. International manufacturers with competitive generic or biosimilar portfolios are well positioned to capture significant market share.
Digital Transformation of INVIMA Processes
INVIMA has been implementing a digital transformation of its regulatory processes, including the INVIMA Virtual platform for online submissions, tracking, and certificate management. These digital improvements are gradually reducing administrative bottlenecks and improving transparency in the evaluation process. Companies that prepare digitally compliant dossiers and understand the platform requirements from the outset gain a meaningful time advantage over competitors.
Everything in Your Report
Every Taevas Global product registration engagement for Colombia Pharmaceuticals delivers a structured set of outputs designed to take your product from regulatory strategy through INVIMA approval and commercial readiness.
Regulatory Strategy Memo
A written assessment of the applicable INVIMA registration pathway, estimated timelines, key risks, and strategic recommendations tailored to your specific pharmaceutical product and market entry objectives.
Complete INVIMA Dossier Package
A fully compiled and quality-reviewed registration dossier in CTD format meeting INVIMA's administrative and technical requirements, prepared in Spanish and ready for official submission.
Pre-Submission Gap Analysis Report
A structured gap analysis identifying missing documents, studies, or certificates required to complete the dossier, with prioritized action items and recommended resolution approaches.
GMP Compliance Assessment
A review of your manufacturing site's GMP documentation against INVIMA's requirements, with a clear assessment of whether existing certifications are sufficient or additional steps are needed.
Local Representative Contracting Support
Identification and vetting of qualified Colombian local representatives, plus preparation of the legal authorization documentation required by INVIMA for foreign company registrations.
INVIMA Submission Confirmation and Tracker
Official filing confirmation from the INVIMA portal along with a live document tracker providing weekly status updates on evaluation progress and any pending actions.
Technical Query Response Package
Professionally drafted responses to all INVIMA technical queries or requests for additional information, prepared by regulatory specialists with direct knowledge of INVIMA evaluator expectations.
Post-Approval Compliance Guide
A comprehensive guide covering post-registration obligations including pharmacovigilance reporting, label variation procedures, renewal timelines, and ongoing INVIMA compliance requirements for your registered product.
Built for These Situations
International Pharma Manufacturer Entering Colombia
Your company has established products approved in the United States, European Union, or other major markets and is now targeting Colombia as a strategic Latin American expansion. You need a reliable regulatory partner who understands INVIMA's requirements, can manage the full registration process in-country, and will keep your timeline on track without requiring you to build internal Colombia regulatory expertise from scratch.
After Product Registration, Most Clients Move To
Common Questions
Ready to Map Your Colombia Opportunity?
Taevas Global's regulatory specialists are ready to assess your pharmaceutical product portfolio and design a clear, efficient INVIMA registration strategy for the Colombia market. Contact us today to begin your market entry journey.